Agenus, Inc. (AGEN)
3.16
-0.07
(-2.17%)
USD |
NASDAQ |
Jun 08, 14:51
Agenus EPS Diluted (Quarterly) : 1.023 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | -0.1889 |
| AnaptysBio, Inc. | -1.843 |
| Amarin Corp. Plc | -0.501 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 39.21M |
| Revenue (Quarterly) | 33.74M |
| Total Expenses (Quarterly) | -5.49M |
| Enterprise Value | 387.13M |
| Gross Profit Margin (Quarterly) | 98.27% |
| Earnings Yield | 52.83% |
| Operating Earnings Yield | 7.34% |
| Normalized Earnings Yield | 1.829 |